Science
CAR NKT cells offer a promising approach to combating difficult-to-treat solid… – AlKhaleej Today
CAR NKT cells offer a promising approach to combating difficult-to-treat solid…
Reviewed by Emily Henderson, B.Sc.October 13, 2020Natural killer T cells (NKT), a type of immune cell known for their potent anti-cancer properties in murine tumor models, have been developed into a novel form of immunotherapy for treating cancer patients.
Researchers at Baylor College of Medicine and the University of North Carolina at Chapel Hill have genetically engineered human NKT cells with a chimeric antigen receptor (CAR) that allows them to specifically recognize neuroblastoma, a form…
-
Business13 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business9 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General19 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Noosa News9 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred